A new study published in the Annals of Internal Medicine suggests that women who have a high risk of developing breast cancer can benefit by using the drugs tamoxifen and raloxifene (Evista).
Researchers led by Dr Heidi Nelson from Oregon Health and Science University in Portland analyzed studies which compared the instances of breast cancer among women placebo and tamoxifen.
Breast Cancer Screening using Mammogram
Breast cancer if detected early can be completely cured. Mammography is used to screen women for breast cancer.
Advertisement
The researchers found that around 23.5 women per 1,000 women developed breast cancer among those who took placebo over a period of five years compared to 16.5 percent 1,000 women who took tamoxifen during the same period.
"Tamoxifen is more effective at reducing breast cancer risk, but it has more side effects. Some women have side effects that are not life-threatening but they are uncomfortable and not minor, and cause them to stop medications, such as vaginal discharge, dryness, itching, leg cramps", Nelson said.
Source: Medindia
Source: Medindia
Breast Cancer - Prevention and Management with Lifestyle Changes
Lifestyle choices may or may not cause breast cancer but healthy lifestyle changes can open up avenues beyond breast cancer. Good habits will allow one to fight breast cancer and to live with dignity.
Advertisement
 Breast Cancer during PregnancyManagement of breast cancer during pregnancy or pregnancy associated breast cancer requires special consideration to avoid harm to the fetus. | Advertisement
|
Male Breast Cancer
Most cases of male breast cancer are diagnosed between the ages of 60 and 70 years. Treatment of male breast cancer often involves surgery.
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
